Resultados da pesquisa - safety after focal phase _

Pesquisas alternativas:
focal phase » local phase (Expandir a Pesquisa), local phased (Expandir a Pesquisa), focal plane (Expandir a Pesquisa)

1

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

Por Chou, Yi-Hong, Liang, Ja-Der, Wang, Shen-Yung, Hsu, Shih-Jer, Hu, Jui-Ting, Yang, Sien-Sing, Wang, Hsin-Kai, Lee, Tien-Ying, Tiu, Chui-Mei
Publicado no J Med Ultrasound (2019)

“... vascular-phase imaging agent in characterizing focal liver lesions (FLLs). MATERIALS AND METHODS: From May...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

Por Tumlin, James, Galphin, Claude, Santos, Raul, Rovin, Brad
Publicado no Kidney Int Rep (2017)

“... in patients with treatment-resistant membranous glomerulopathy (MGN) and focal segmental glomerulosclerosis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

Por James Tumlin, Claude Galphin, Raul Santos, Brad Rovin
Publicado em 2017-09-01

Assuntos: “...focal segmental glomerulosclerosis...”
Obter o texto integral

Artigo

4

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

Por Komers, Radko, Diva, Ulysses, Inrig, Jula K., Loewen, Andrea, Trachtman, Howard, Rote, William E.
Publicado no Kidney Int Rep (2020)

“...INTRODUCTION: Focal segmental glomerulosclerosis (FSGS), a histologic lesion in the kidney caused...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

Por Radko Komers, Ulysses Diva, Jula K. Inrig, Andrea Loewen, Howard Trachtman, William E. Rote
Publicado em 2020-04-01

“... analysis at week 36. Safety and tolerability of sparsentan will also be assessed. Conclusion: The phase 3...”
Obter o texto integral

Artigo

6

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Por Trachtman, Howard, Nelson, Peter, Adler, Sharon, Campbell, Kirk N., Chaudhuri, Abanti, Derebail, Vimal Kumar, Gambaro, Giovanni, Gesualdo, Loreto, Gipson, Debbie S., Hogan, Jonathan, Lieberman, Kenneth, Marder, Brad, Meyers, Kevin Edward, Mustafa, Esmat, Radhakrishnan, Jai, Srivastava, Tarak, Stepanians, Miganush, Tesar, Vladimír, Zhdanova, Olga, Komers, Radko
Publicado no J Am Soc Nephrol (2018)

“... irbesartan in patients with primary FSGS. METHODS: In this phase 2, randomized, double-blind, active-control...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group

Por Joy, Melanie S., Gipson, Debbie S., Powell, Leslie, MacHardy, Jacqueline, Jennette, J. Charles, Vento, Suzanne, Pan, Cynthia, Savin, Virginia, Eddy, Allison, Fogo, Agnes B., Kopp, Jeffrey B., Cattran, Daniel, Trachtman, Howard
Publicado em 2009

“...BACKGROUND: Patients with primary focal segmental glomerulosclerosis (FSGS) resistant to current...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee

A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee

Por Takehiko Matsushita, Tomoyuki Matsumoto, Daisuke Araki, Kanto Nagai, Yuichi Hoshino, Takahiro Niikura, Atsuhiko Kawamoto, Masahiro J. Go, Shin Kawamata, Masanori Fukushima, Ryosuke Kuroda
Publicado em 2022-04-01

“... conducted in Japan to assess the safety and effectiveness of third-generation autologous chondrocyte...”
Obter o texto integral

Artigo

9

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

Por Trachtman, Howard, Fervenza, Fernando C, Gipson, Debbie S, Heering, Peter, Jayne, David R W, Peters, Harm, Rota, Stefano, Remuzzi, Giuseppe, Rump, L Christian, Sellin, Lorenz K, Heaton, Jeremy P W, Streisand, James B, Hard, Marjie L, Ledbetter, Steven R, Vincenti, Flavio
Publicado em 2011

“...Primary focal segmental glomerulosclerosis (FSGS) is a disease with poor prognosis and high unmet...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

$Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience$

Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset...

Por Gama, Helena, Vieira, Mariana, Costa, Raquel, Graça, Joana, Magalhães, Luís M., Soares-da-Silva, Patrício
Publicado no Drug Saf (2017)

“... safety analysis of four phase III, double-blind, randomized, placebo-controlled studies (BIA-2093-301...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Phase I trial: safety and feasibility of intracranial electroencephalography using hybrid subdural electrodes containing macro- and microelectrode arrays

Phase I trial: safety and feasibility of intracranial electroencephalography using hybrid subdural electrodes containing macro- and microelectrode arrays

Por Van Gompel, Jamie J., Stead, S. Matthew, Giannini, Caterina, Meyer, Fredric B., Marsh, W. Richard, Fountain, Todd, So, Elson, Cohen-Gadol, Aaron, Lee, Kendall H., Worrell, Gregory A.
Publicado em 2008

“... electroencephalography (iEEG). However, the safety of hybrid electrode systems containing standard clinical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Initial Experience of Targeted Focal Interstitial Laser Ablation of Prostate Cancer with MRI Guidance

Initial Experience of Targeted Focal Interstitial Laser Ablation of Prostate Cancer with MRI Guidance

Por Barqawi, Al, Krughoff, Kevin, Li, Hongli, Patel, Nayana U.
Publicado no Curr Urol (2015)

“... patients. In the first phase of the procedure the patient's prostate was aligned to a position concordant...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Exposure‐safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate

Exposure‐safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate

Por Gidal, B. E., Jacobson, M. P., Ben‐Menachem, E., Carreño, M., Blum, D., Soares‐da‐Silva, P., Falcão, A., Rocha, F., Moreira, J., Grinnell, T., Ludwig, E., Fiedler‐Kelly, J., Passarell, J., Sunkaraneni, S.
Publicado no Acta Neurol Scand (2018)

“... exposure and safety and efficacy outcomes from Phase 3 trials of adjunctive ESL. METHODS: Eslicarbazepine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study

A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study

Publicado em 2007

“... by focal photocoagulation after 4 weeks (N = 25), 40 mg posterior subtenon's injection of triamcinolone (N...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Phase I Trial of Rosiglitazone in FSGS: I. Report of the FONT Study Group

Phase I Trial of Rosiglitazone in FSGS: I. Report of the FONT Study Group

Por Joy, Melanie S., Gipson, Debbie S., Dike, Mary, Powell, Leslie, Thompson, Amber, Vento, Suzanne, Eddy, Allison, Fogo, Agnes B., Kopp, Jeffrey B., Cattran, Daniel, Trachtman, Howard
Publicado em 2009

“...Background and objectives: Patients with primary focal segmental glomerulosclerosis (FSGS) who...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety

Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety

Por Blum, Alexander B, Shea, Sandra, Czeisler, Charles A, Landrigan, Christopher P, Leape, Lucian
Publicado em 2011

“... public safety across safety-sensitive industries, with the notable exception of medicine. In late 2007...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma

Por Rubenstein, James L., Geng, Huimin, Fraser, Eleanor J., Formaker, Paul, Chen, Lingjing, Sharma, Jigyasa, Killea, Phoebe, Choi, Kaylee, Ventura, Jenny, Kurhanewicz, John, Lowell, Clifford, Hwang, Jimmy, Treseler, Patrick, Sneed, Penny K., Li, Jing, Wang, Xiaomin, Chen, Nianhang, Gangoiti, Jon, Munster, Pamela N., Damato, Bertil
Publicado no Blood Adv (2018)

“.... In an independent cohort, we evaluated lenalidomide maintenance after salvage with high-dose methotrexate or focal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Transcranial focal electrical stimulation via tripolar concentric ring electrodes does not modify the short- and long-term memory formation in rats evaluated in the novel object recognition test

Transcranial focal electrical stimulation via tripolar concentric ring electrodes does not modify...

Por Rogel-Salazar, G, Luna-Munguía, H, Stevens, KE, Besio, WG
Publicado em 2013

“... of healthy rats as a safety test of TFS. The short and long-term memory formation was tested after...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

PDCT-03. PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN PEDIATRIC BRAIN TUMORS

PDCT-03. PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN PEDIATRIC BRAIN TUMORS

Por Goldman, Stewart, Kieran, Mark, Mueller, Sabine, Buck, Jill, MacKenna, Richard, Barrett, John, Cooper, Laurence, Lebel, Francois
Publicado no Neuro Oncol (2017)

“... on encouraging data from an ongoing phase I dose escalation trial in adults with recurrent/progressive glioma...”
Obter o texto integral
Obter o texto integral

Artigo

20

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING

MBCL-32. SAFETY AND EFFICACY OF CONCURRENT CARBOPLATIN DURING CRANIOSPINAL IRRADIATION FOR HIGH-RISK/ MEDULLOBLASTOMA IN A RESOURCE-LIMITED SETTING

Por Gupta, Tejpal, Chinnaswamy, Girish, Sankaran, Hari, Vora, Tushar, Prasad, Maya, Epari, Sridhar, Sahay, Ayushi, Moiyadi, Aliasgar, Shetty, Prakash, Shirsat, Neelam, Krishnatry, Rahul, Sastri, GodaJayant, Jalali, Rakesh
Publicado no Neuro Oncol (2018)

“...PURPOSE: To review the safety and efficacy of concurrent carboplatin during craniospinal...”
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
Seguinte
[3]